Patent application number | Description | Published |
20090202439 | Methods for treatment of angiogenesis - The present invention includes methods for treatment and prophylaxis of diseases, post-surgical disorders and bacterial infections associated with lactosylceramide. The methods generally provide for administration to a subject one or more compounds that alter the activity of VEGF pathway members, including LacCer synthase (GalT-V/VI), PECAM1, VEGFR, VEGF or related pathway members to treat a subject suffering from or susceptible to a condition caused or contributed to by VEGF. The present invention also relates to methods for detecting and analyzing compounds with therapeutic capacity to treat such condition. | 08-13-2009 |
20090208934 | PECAM-1 GENOTYPE - The invention relates to methods of identifying inter-patient differences in genotype of PECAM- | 08-20-2009 |
20090215171 | PELCAM-1-related molecules compositions kit of parts and associated methods of use - An isolated polynucleotide coding for platelet endothelial cell adhesion molecule-1 (PECAM-1), and obtainable by amplifying cDNA from total human white blood cells by PCR; peptides encoding PECAM-1 5 | 08-27-2009 |
20100063153 | ANTI-CHOLESTEROLEMIC COMPOUNDS AND METHODS OF USE - The present invention provides novel compounds with hypocholesteremic activity from crude | 03-11-2010 |
20130041015 | Use of the Lactosylceramide Synthase Isoform B1,4GALT-V as a Biomarker for Cancer - In one aspect, B1,4GalT-V, an isoform of the enzyme lactosylceramide synthase, is provided as a biomarker for cancer. Also provided are methods and compositions directed at cancers characterized by the overexpression or upregulation of the lactosylceramide synthase isoform B1,4GalT-V. | 02-14-2013 |
20140031304 | ANTI-CHOLESTEROLEMIC COMPOUNDS AND METHODS OF USE - The present invention provides novel compounds with hypocholesteremic activity from crude | 01-30-2014 |
20140141017 | METHODS OF DIAGNOSING ATHEROSCLEROSIS BY MEASURING APOCI - The present invention provides methods and compositions for identifying compounds which inhibit ApoCI and which are useful in the treatment or prevention of atherosclerosis, plaque rupture, apoptosis, or myocardial infarction. The invention further provides methods for treating subjects suffering from or at risk of developing atherosclerosis, plaque rupture, apoptosis, or myocardial infarction. The invention further provides methods for diagnosing subjects at suffering from or at risk of developing treatment or prevention of atherosclerosis, plaque rupture, apoptosis, or myocardial infarction. | 05-22-2014 |
20140193846 | NOVEL APOC-I ISOFORMS AND THEIR USE AS BIOMARKERS AND RISK FACTORS OF ATHEROSCLEROTIC DISEASE - Novel isoforms of apolipoprotein C-I (apoC-I), namely apolipoprotein C-I | 07-10-2014 |